SCHEMBL4634229

SCHEMBL4634229

CCCCOc1nc(N)c2[nH]c(=O)n(CCCN(CCCN(C)C)Cc3cccc(OC(C)=O)c3)c2n1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 19/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633208 0.97 TLR7 (0.53) TLR7
SCHEMBL4634184 0.91 TLR7 (0.57) TLR7
SCHEMBL4666608 0.91 TLR7 (0.61) TLR7
SCHEMBL2840336 0.89 TLR7 (0.66) TLR7
SCHEMBL2862789 0.88 TLR7 (0.60) TLR7
SCHEMBL30164530 0.87 TLR7 (0.71) TLR7
SCHEMBL13798671 0.87 TLR7 (0.71) TLR7
SCHEMBL5964498 0.86 TLR7 (0.64) TLR7
SCHEMBL1244619 0.86 TLR7 (0.62) TLR7
SCHEMBL4132122 0.85 TLR7 (0.60) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928876-A1 PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES AstraZeneca AB (SE) 2008-06-11 EP disclosed
WO-2007031726-A1 PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES ASTRAZENECA AB (SE) 2007-03-22 WO disclosed